THE WORLD’S FIRST 4D SKIN TESTING PLATFORM, MIMICKING BLOOD FLOW, IS FAR MORE ACCURATE, FULLY AUTOMATED, COST-EFFECTIVE, AND CRUELTY-FREE BY REVIVO BIOSYSTEMS
Now Medelink introduces and represents RELEGO™ and REVEX™, the world’s first 4D Skin testing platform in Canada and USA. It has been launched by REVIVO BioSystems, a leading Singapore-based organ-on-chip company.
The system works as a fraction collector that automates procedures with liquid handling and time-based sampling, ReleGO™ accommodates four REVex™ chips — single-use microfluidic devices for testing the safety and efficacy of chemicals, active ingredients, and product formulations on tissue explants or simulants. Each chip has 3 chambers, allowing as many as 12 unique tests to be run simultaneously in one ReleGO™. Additionally, because protocols are fully automated, the product also eliminates the long and complicated manual process.